Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Safety and pharmacokinetics of nelfinavir during the second and third trimesters of pregnancy and postpartum.

Fang A, Valluri SR, O'Sullivan MJ, Maupin R, Jones T, Delke I, Clax P.

HIV Clin Trials. 2012 Jan-Feb;13(1):46-59. doi: 10.1310/hct1301-046.

PMID:
22306587
[PubMed - indexed for MEDLINE]
2.

Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353.

Bryson YJ, Mirochnick M, Stek A, Mofenson LM, Connor J, Capparelli E, Watts DH, Huang S, Hughes MD, Kaiser K, Purdue L, Asfaw Y, Keller M, Smith E; PACTG 353 Team.

HIV Clin Trials. 2008 Mar-Apr;9(2):115-25. doi: 10.1310/hct0902-115.

PMID:
18474496
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum.

Read JS, Best BM, Stek AM, Hu C, Capparelli EV, Holland DT, Burchett SK, Smith ME, Sheeran EC, Shearer WT, Febo I, Mirochnick M.

HIV Med. 2008 Nov;9(10):875-82. doi: 10.1111/j.1468-1293.2008.00640.x. Epub 2008 Sep 14.

PMID:
18795962
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Nelfinavir and nevirapine side effects during pregnancy.

Timmermans S, Tempelman C, Godfried MH, Nellen J, Dieleman J, Sprenger H, Schneider ME, de Wolf F, Boer K, van der Ende ME; Dutch HMF Study Group.

AIDS. 2005 May 20;19(8):795-9.

PMID:
15867493
[PubMed - indexed for MEDLINE]
5.

A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).

Podzamczer D, Ferrer E, Consiglio E, Gatell JM, Perez P, Perez JL, Luna E, González A, Pedrol E, Lozano L, Ocaña I, Llibre JM, Casiró A, Aranda M, Barrufet P, Martínez-Lacasa J, Miró JM, Badía X, Casado A, Lupo S, Cahn P, Maños M, Estela J.

Antivir Ther. 2002 Jun;7(2):81-90.

PMID:
12212928
[PubMed - indexed for MEDLINE]
6.

Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results.

Murphy RL, Sanne I, Cahn P, Phanuphak P, Percival L, Kelleher T, Giordano M.

AIDS. 2003 Dec 5;17(18):2603-14.

PMID:
14685054
[PubMed - indexed for MEDLINE]
7.

Long-term responses to treatment including ritonavir or nelfinavir in HIV-1-infected children. Pediatric AIDS Group of Switzerland.

Nadal D, Steiner F, Cheseaux JJ, Lazarevitch CA, Aebi C, Kind C, Rudin C.

Infection. 2000 Sep;28(5):287-96. Erratum in: Infection 2000 Nov-Dec;28(6):402.

PMID:
11073135
[PubMed - indexed for MEDLINE]
9.

Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.

Kakehasi FM, Tupinambás U, Cleto S, Aleixo A, Lin E, Melo VH, Aguiar RA, Pinto JA.

AIDS Res Hum Retroviruses. 2007 Dec;23(12):1515-20.

PMID:
18160009
[PubMed - indexed for MEDLINE]
10.

Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission.

Vithayasai V, Moyle GJ, Supajatura V, Wattanatchariya N, Kanshana S, Sirichthaporn P, Dabtham K, Somburanasin P, Chantawuttinan T, Hill AM, Hawkins D.

J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):410-2.

PMID:
12138347
[PubMed - indexed for MEDLINE]
11.

A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.

Kumar PN, Rodriguez-French A, Thompson MA, Tashima KT, Averitt D, Wannamaker PG, Williams VC, Shaefer MS, Pakes GE, Pappa KA; ESS40002 Study Team.

HIV Med. 2006 Mar;7(2):85-98.

PMID:
16420253
[PubMed - indexed for MEDLINE]
12.

Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).

Saag MS, Tebas P, Sension M, Conant M, Myers R, Chapman SK, Anderson R, Clendeninn N; Virqacept Collaborative Study Group.

AIDS. 2001 Oct 19;15(15):1971-8.

PMID:
11600825
[PubMed - indexed for MEDLINE]
13.

The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.

Elion R, Kaul S, Knupp C, Adler M, Cross AP, Dunkle LM, Kelleher T.

Clin Ther. 1999 Nov;21(11):1853-63.

PMID:
10890257
[PubMed - indexed for MEDLINE]
14.

The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum.

van Heeswijk RP, Khaliq Y, Gallicano KD, Bourbeau M, Seguin I, Phillips EJ, Cameron DW.

Clin Pharmacol Ther. 2004 Dec;76(6):588-97.

PMID:
15592330
[PubMed - indexed for MEDLINE]
15.

A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team.

Haubrich R, Thompson M, Schooley R, Lang W, Stein A, Sereni D, van der Ende ME, Antunes F, Richman D, Pagano G, Kahl L, Fetter A, Brown DJ, Clumeck N.

AIDS. 1999 Dec 3;13(17):2411-20.

PMID:
10597783
[PubMed - indexed for MEDLINE]
16.

Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate.

Krogstad P, Wiznia A, Luzuriaga K, Dankner W, Nielsen K, Gersten M, Kerr B, Hendricks A, Boczany B, Rosenberg M, Jung D, Spector SA, Bryson Y.

Clin Infect Dis. 1999 May;28(5):1109-18.

PMID:
10452644
[PubMed - indexed for MEDLINE]
Free Article
17.

Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.

Lorenzi P, Spicher VM, Laubereau B, Hirschel B, Kind C, Rudin C, Irion O, Kaiser L.

AIDS. 1998 Dec 24;12(18):F241-7.

PMID:
9875571
[PubMed - indexed for MEDLINE]
18.

Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children.

Rudin C, Burri M, Shen Y, Rode R, Nadal D; Pediatric Infectious Disease Group of Switzerland; Swiss Mother and Child HIV Cohort Study (MoCHiV).

Pediatr Infect Dis J. 2008 May;27(5):431-7. doi: 10.1097/INF.0b013e3181646d5a.

PMID:
18382386
[PubMed - indexed for MEDLINE]
19.

Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expression.

Ford J, Cornforth D, Hoggard PG, Cuthbertson Z, Meaden ER, Williams I, Johnson M, Daniels E, Hsyu P, Back DJ, Khoo SH.

Antivir Ther. 2004 Feb;9(1):77-84.

PMID:
15040539
[PubMed - indexed for MEDLINE]
20.

Anti-HIV agents. Nelfinavir levels during pregnancy.

[No authors listed]

TreatmentUpdate. 2004 Apr-May;16(3):5-6. No abstract available.

PMID:
17216835
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk